Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel, Gemcitabine and Cisplatin in Relapsing Germ Cell Cancer
NCT00531687Phase 2Terminated
- Sponsor
- Rigshospitalet
- Start
- Sep 2007
- Primary completion
- Feb 2012
- Modality
- Nanoparticles, Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, gemcitabine, Cisplatin micelle injection (HA132) in germ cell tumor (GCT), sponsored by Rigshospitalet. Started Sep 2007; status: terminated.
02
Drugs
Paclitaxel Micelles for InjectiongemcitabineCisplatin micelle injection (HA132)
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00531687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531687.